Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$3.79 - $8.3 $18,950 - $41,500
5,000 Added 16.61%
35,100 $149,000
Q1 2023

Apr 19, 2023

SELL
$5.89 - $10.52 $3,534 - $6,312
-600 Reduced 1.95%
30,100 $205,000
Q4 2022

Jan 24, 2023

SELL
$5.69 - $10.07 $569 - $1,007
-100 Reduced 0.32%
30,700 $243,000
Q3 2022

Oct 19, 2022

SELL
$7.17 - $13.87 $2,151 - $4,161
-300 Reduced 0.96%
30,800 $296,000
Q2 2022

Jul 20, 2022

BUY
$5.86 - $13.23 $586 - $1,323
100 Added 0.32%
31,100 $237,000
Q1 2022

Apr 22, 2022

BUY
$10.92 - $16.41 $1,092 - $1,641
100 Added 0.32%
31,000 $313,000
Q4 2021

Jan 14, 2022

BUY
$15.81 - $18.99 $4,743 - $5,696
300 Added 0.98%
30,900 $493,000
Q3 2021

Oct 12, 2021

BUY
$12.68 - $17.79 $6,340 - $8,895
500 Added 1.66%
30,600 $492,000
Q2 2021

Jul 16, 2021

BUY
$12.95 - $15.41 $12,950 - $15,410
1,000 Added 3.44%
30,100 $416,000
Q1 2021

Apr 14, 2021

SELL
$14.42 - $21.39 $1,442 - $2,139
-100 Reduced 0.34%
29,100 $425,000
Q4 2020

Jan 11, 2021

BUY
$16.56 - $18.94 $1,655 - $1,894
100 Added 0.34%
29,200 $507,000
Q3 2020

Oct 19, 2020

BUY
$17.41 - $19.89 $217,625 - $248,625
12,500 Added 75.3%
29,100 $534,000
Q2 2020

Jul 13, 2020

BUY
$14.43 - $19.16 $239,538 - $318,056
16,600 New
16,600 $296,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $115M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.